María José Santiago Lozano

Dr. María José Santiago Lozano

Hospital General Universitario Gregorio Marañón, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
María Dolores MesaMaría Dolores Mesa
María Dolores Mesa
BLBegoña Loureiro
Begoña Loureiro
IIIris Iglesia
Iris Iglesia
SGSergi Fernandez Gonzalez
Sergi Fernandez Gonzalez
EOElisa Llurba Olivé
Elisa Llurba Olivé
FCFernando Cabañas
Fernando Cabañas
Pregnancy induces a number of immunological, hormonal, and metabolic changes that are necessary for the mother to adapt her body to this new physiological situation. The microbiome of the mother, the placenta and the fetus influence the fetus growth and undoubtedly plays a major role in the adequate development of the newborn infant. Hence, the microbiome modulates the inflammatory mechanisms related to physiological and pathological processes that are involved in the perinatal progress through different mechanisms. The present review summarizes the actual knowledge related to physiological changes in the microbiota occurring in the mother, the fetus, and the child, both during neonatal period and beyond. In addition, we approach some specific pathological situations during the perinatal periods, as well as the influence of the type of delivery and feeding.

27 March 2013 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
JMJuan Mayordomo-Colunga
Juan Mayordomo-Colunga
MPMartí Pons-Òdena
Martí Pons-Òdena
YLYolanda López
Yolanda López
María José Santiago LozanoMaría José Santiago Lozano
María José Santiago Lozano
Corsino GalánCorsino Galán
Corsino Galán
EOEider Oñate
Eider Oñate

23 November 2009 in Critical Care
Verified
Journal Article
Open access
PDF file
María José Santiago LozanoMaría José Santiago Lozano
María José Santiago Lozano
JLJesús LópezHerce
Jesús LópezHerce
JUJavier Urbano
Javier Urbano
María José Santiago LozanoMaría José Santiago Lozano
María José Santiago Lozano
JCJimena del Castillo
Jimena del Castillo
JBJosé María Bellón-Cano
José María Bellón-Cano
Introduction: Continuous renal replacement therapy (CRRT) frequently gives rise to complications in critically ill children. However, no studies have analyzed these complications prospectively. The purpose of this study was to analyze the complications of CRRT in children and to study the associated risk factors. Methods: A prospective, single-centre, observational study was performed in all critically ill children treated using CRRT in order to determine the incidence of complications related to the technique (problems of catheterization, hypotension at the time of connection to the CRRT, hemorrhage, electrolyte disturbances) and their relationship with patient characteristics, clinical severity, need for vasoactive drugs and mechanical ventilation, and the characteristics of the filtration techniques. Results: Of 174 children treated with CRRT, 13 (7.4%) presented problems of venous catheterization; this complication was significantly more common in children under 12 months of age and in those weighing less than 10 kg. Hypotension on connection to CRRT was detected in 53 patients (30.4%). Hypotension was not associated with any patient or CRRT characteristics. Clinically significant hemorrhage occurred in 18 patients (10.3%); this complication was not related to any of the variables studied. The sodium, chloride, and phosphate levels fell during the first 72 hours of CRRT; the changes in electrolyte levels during the course of treatment were not found to be related to any of the variables analyzed, nor were they associated with mortality. Conclusions: CRRT-related complications are common in children and some are potentially serious. The most common are hypotension at the time of connection and electrolyte disturbances. Strict control and continuous monitoring of the technique are therefore necessary in children on CRRT.

1 July 2011 in The Journal of Pediatrics
Verified
Journal Article
Closed access
MBMarta Botrán
Marta Botrán
JLJesús LópezHerce
Jesús LópezHerce
SMSantiago Mencía
Santiago Mencía
JUJavier Urbano
Javier Urbano
María José Santiago LozanoMaría José Santiago Lozano
María José Santiago Lozano
AGAna García
Ana García

18 March 2010 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
MSMaria J. Santiago
Maria J. Santiago
JLJesús LópezHerce
Jesús LópezHerce
JUJavier Urbano
Javier Urbano
María José Santiago LozanoMaría José Santiago Lozano
María José Santiago Lozano
JCJimena del Castillo
Jimena del Castillo
JBJose María Bellón
Jose María Bellón

25 July 2008 in Critical Care
Verified
Journal Article
Open access
PDF file
JCJimena del Castillo
Jimena del Castillo
JLJesús LópezHerce
Jesús LópezHerce
ECElena Cidoncha
Elena Cidoncha
JUJavier Urbano
Javier Urbano
SMSantiago Mencía
Santiago Mencía
JBJosé María Bellón-Cano
José María Bellón-Cano
Introduction: One of the greatest problems with continuous renal replacement therapy (CRRT) is early coagulation of the filters. Few studies have monitored circuit function prospectively. The purpose of this study was to determine the variables associated with circuit life in critically ill children with CRRT. Methods: A prospective observational study was performed in 122 children treated with CRRT in a pediatric intensive care unit from 1996 to 2006. Patient and filter characteristics were analyzed to determine their influence on circuit life. Data were collected on 540 filters in 122 patients and an analysis was performed of the 365 filters (67.6%) that were changed due to circuit coagulation. Results: The median circuit life was 31 hours (range 1 to 293 hours). A univariate and multivariate logistic regression study was performed to assess the influence of each one of the factors on circuit life span. No significant differences in filter life were found according to age, weight, diagnoses, pump, site of venous access, blood flow rate, ultrafiltration rate, inotropic drug support, or patient outcome. The mean circuit life span was longer when the heparin dose was greater than 20 U/kg per hour (39 versus 29.1 hours; P = 0.008), with hemodiafiltration compared with hemofiltration (34 versus 22.7 hours; P = 0.001), with filters with surface areas of 0.4 to 0.9 m2 (38.2 versus 26.1 hours; P = 0.01), and with a catheter size of 6.5 French or greater (33.0 versus 25.0 hours; P = 0.04). In the multivariate analysis, hemodiafiltration, heparin dose of greater than 20 U/kg per hour, filter surface area of 0.4 m2 or greater, and initial creatinine of less than 2 mg/dL were associated with a filter life of more than 24 and 48 hours. Total effluent rate of greater than 35 mL/kg per hour was associated only with a filter life of more than 24 hours. Conclusion: Circuit life span in CRRT in children is short but may be increased by the use of hemodiafiltration, higher heparin doses, and filters with a high surface area.